Biotech

News

Treeline's $200m Series A extension, and other biofinancings

Recent biotech financings include a $200m round for Treeline, with Enveda, Wugen, CHARM Therapeutics, and MRM Health also in on the action.

Market Access

Biotech ≠ tech: Why venture capital needs a new playbook for...

Silicon Valley investors have been conditioned by two decades of software: launch quickly, capture users faster, and hit the magic $1 million ARR mark within about three years,1

News

Strand raises $153m for RNA meds, and other bio financings

Recent financings in biotech include a $153m Series B for programmable mRNA developer Strand, plus rounds for Artbio, Minghui, and Chai Discovery.

News

Cellular Origin's Constellation robotic system for cell and gene therapy manufacturing

UK project addresses capacity issue in CGT manufacturing

A UK consortium has been set up to tackle a major issue in the development of cell and gene therapies (CGT) – a lack of manufacturing capacity.

News

Cash injection will help Varda make drugs in space

A new US startup, called Varda Space Industries, has raised $187 million in financing for a bold plan to manufacture medicines in orbit.

News

New radiopharma Actithera emerges with $75.5m in financing

A new player in radioligand therapies, Actithera, has arrived on the scene with $75.5m in funding and lead FAP-targeted candidate for cancer.

Treeline's $200m Series A extension, and other biofinancings

Biotech ≠ tech: Why venture capital needs a new playbook for...

Strand raises $153m for RNA meds, and other bio financings

UK project addresses capacity issue in CGT manufacturing

Cash injection will help Varda make drugs in space

New radiopharma Actithera emerges with $75.5m in financing

FDA points to liver injury with Amgen's Tavneos

Using AI-driven synthetic personas to take your insights fur...

Biotech

Editor's Picks